Goldman Sachs’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q3
Sell
-218,143
Closed -$22.2M 5053
2023
Q2
$22.2M Buy
218,143
+75,344
+53% +$7.68M ﹤0.01% 1477
2023
Q1
$13M Sell
142,799
-130,419
-48% -$11.9M ﹤0.01% 1818
2022
Q4
$10.4M Sell
273,218
-74,512
-21% -$2.83M ﹤0.01% 2103
2022
Q3
$8.74M Buy
347,730
+271,475
+356% +$6.82M ﹤0.01% 2237
2022
Q2
$2.32M Sell
76,255
-31,102
-29% -$945K ﹤0.01% 3321
2022
Q1
$3.52M Sell
107,357
-1,075,213
-91% -$35.2M ﹤0.01% 3085
2021
Q4
$31.2M Buy
1,182,570
+1,005,161
+567% +$26.5M 0.01% 1447
2021
Q3
$17.8M Buy
177,409
+115,525
+187% +$11.6M ﹤0.01% 1827
2021
Q2
$8.76M Sell
61,884
-169,867
-73% -$24M ﹤0.01% 2351
2021
Q1
$23.1M Sell
231,751
-1,473
-0.6% -$147K 0.01% 1584
2020
Q4
$28.8M Sell
233,224
-76,386
-25% -$9.44M 0.01% 1304
2020
Q3
$30.2M Buy
309,610
+29,121
+10% +$2.84M 0.01% 1210
2020
Q2
$43.8M Buy
280,489
+108,047
+63% +$16.9M 0.01% 942
2020
Q1
$24.9M Buy
172,442
+10,424
+6% +$1.5M 0.01% 1203
2019
Q4
$33.1M Buy
162,018
+32,521
+25% +$6.65M 0.01% 1284
2019
Q3
$10.4M Buy
129,497
+50,363
+64% +$4.04M ﹤0.01% 1910
2019
Q2
$7.47M Sell
79,134
-3,269
-4% -$308K ﹤0.01% 2110
2019
Q1
$7.04M Buy
82,403
+38,632
+88% +$3.3M ﹤0.01% 2234
2018
Q4
$2.46M Buy
43,771
+19,390
+80% +$1.09M ﹤0.01% 2706
2018
Q3
$1.99M Sell
24,381
-5,909
-20% -$483K ﹤0.01% 2883
2018
Q2
$1.06M Buy
30,290
+818
+3% +$28.6K ﹤0.01% 3170
2018
Q1
$604K Buy
29,472
+18,623
+172% +$382K ﹤0.01% 3409
2017
Q4
$307K Buy
+10,849
New +$307K ﹤0.01% 3647
2016
Q4
Sell
-8,542
Closed -$225K 4599
2016
Q3
$225K Sell
8,542
-46,562
-84% -$1.23M ﹤0.01% 3860
2016
Q2
$1.09M Buy
+55,104
New +$1.09M ﹤0.01% 2905